Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 6,191 shares at $24.53 ($152K) on 2022-07-18, disclosed to the SEC on 2022-07-20.
Open-market sale of $152k PCVX by President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.53 | 3,091 | $76K | 49.9% |
| 2 | $24.53 | 3,091 | $76K | 49.9% |
| 3 | $25.00 | 9 | $225 | 0.1% |
| Total | $24.53 avg | 6,191 | $152K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |